LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SHAK
Shake Shack Inc.
SHAK has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SHAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
SHAK's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SHAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 71x | $72.68 | — |
| Cheap | 75x | $77.60 | +6.8% |
| Fair | 153x | $158 | +117% |
| Expensive | 505x | $520 | +616% |
Historical ranges are pointers, not guarantees.
SHAK's PE is in its cheap range at 71x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SHAK Forward outlook
There aren't enough analyst estimates for SHAK to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SHAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.03 | 0% |
| Q2 2026 | $0.94 | +100% |
| Q1 2026 | $0.98 | +238% |
| Q4 2025 | $1.09 | +354% |
| Q3 2025 | $1.03 | +442% |
| Q2 2025 | $0.47 | -27% |
| Q1 2025 | $0.29 | -49% |
| Q4 2024 | $0.24 | -50% |
SHAK has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SHAK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SHAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $423.3M | +15% |
| Q2 2026 | $417.6M | +17% |
| Q1 2026 | $366.7M | +14% |
| Q4 2025 | $400.5M | +22% |
| Q3 2025 | $367.4M | +16% |
| Q2 2025 | $356.5M | +13% |
| Q1 2025 | $320.9M | +10% |
| Q4 2024 | $328.7M | +15% |
SHAK's revenue has grown year over year every quarter since late 2020: $423M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | 0 points |
| Q2 2026 | 5% | -1.3 points |
| Q1 2026 | -0.7% | -1.6 points |
| Q4 2025 | 4.7% | +1.6 points |
| Q3 2025 | 5% | +11 points |
| Q2 2025 | 6.3% | +2.9 points |
| Q1 2025 | 0.9% | +0.9 points |
| Q4 2024 | 3.1% | +3.6 points |
SHAK has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SHAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.1M | -45% |
| Q2 2026 | -$736K | -103% |
| Q1 2026 | -$38.7M | -2170% |
| Q4 2025 | $4M | -62% |
| Q3 2025 | $23.7M | +237% |
| Q2 2025 | $26.9M | +31% |
| Q1 2025 | $1.9M | +$4.3M |
| Q4 2024 | $10.4M | +23% |
SHAK has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SHAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +44K shares |
| 1 year | +0.1% | +36K shares |
| 3 years | -4.7% | -2.1M shares |
| 5 years | +7.1% | +2.8M shares |
| Available history | +30% | +9.7M shares |
SHAK has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SHAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
SHAK has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SHAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 75.5 | Neutral |
SHAK's weekly RSI is 53 (neutral) and its Stochastic is 76 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SHAK PE vs Consumer Cyclical Sector
| Metric | SHAK | Sector median | Relative |
|---|---|---|---|
| PE | 71x | 18x | 292% above |
| PE % | 11 | 47 | 36 pts below |
SHAK is trading at 71x earnings, a 292% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SHAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.7 | 9% above |
| 20 week MA | $65.3 | 11% above |
| 50 week MA | $75.9 | 4.3% below |
| 100 week MA | $92.0 | 21% below |
| 200 week MA | $86.9 | 16% below |
SHAK has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SHAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.5 | $87.8 | +45% |
| 2021 | $87.8 | $74.5 | -15% |
| 2022 | $74.5 | $44.9 | -40% |
| 2023 | $44.9 | $74.1 | +65% |
| 2024 | $74.1 | $132.6 | +79% |
| 2025 | $132.6 | $83.8 | -37% |
| 2026 YTD | $83.8 | $72.7 | -13% |
SHAK has the edge over LCID on returns for 2026, with the stronger performance.